Kang Ke Ren - Net Worth and Insider Trading

Kang Ke Ren Net Worth

The estimated net worth of Kang Ke Ren is at least $5 Million dollars as of 2024-06-23. Kang Ke Ren is the Executives of Guangzhou Wondfo Biotech Co Ltd and owns about 206,100 shares of Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) stock worth over $5 Million. Details can be seen in Kang Ke Ren's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kang Ke Ren has not made any transactions after 2022-12-23 and currently still holds the listed stock(s).

Transaction Summary of Kang Ke Ren

Kang Ke Ren Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kang Ke Ren owns 1 companies in total, including Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) .

Click here to see the complete history of Kang Ke Ren’s form 4 insider trades.

Insider Ownership Summary of Kang Ke Ren

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300482	Guangzhou Wondfo Biotech Co Ltd	2022-12-23	Executives

Kang Ke Ren Latest Holdings Summary

Kang Ke Ren currently owns a total of 1 stock. Kang Ke Ren owns 206,100 shares of Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) as of December 23, 2022, with a value of $5 Million.

Latest Holdings of Kang Ke Ren

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300482	Guangzhou Wondfo Biotech Co Ltd	2022-12-23	206,100	26.39	5,438,979

Holding Weightings of Kang Ke Ren

Kang Ke Ren Form 4 Trading Tracker

According to the SEC Form 4 filings, Kang Ke Ren has made a total of 6 transactions in Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Guangzhou Wondfo Biotech Co Ltd is the sale of 76,500 shares on December 23, 2022, which brought Kang Ke Ren around $3 Million.

Insider Trading History of Kang Ke Ren

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kang Ke Ren Trading Performance

GuruFocus tracks the stock performance after each of Kang Ke Ren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kang Ke Ren is 21.55%. GuruFocus also compares Kang Ke Ren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kang Ke Ren within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kang Ke Ren's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kang Ke Ren

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-0.48
Relative Return to S&P 500(%)	-2.9

Kang Ke Ren Ownership Network

Ownership Network List of Kang Ke Ren

No Data

Ownership Network Relation of Kang Ke Ren

Kang Ke Ren Owned Company Details

What does Guangzhou Wondfo Biotech Co Ltd do?

Who are the key executives at Guangzhou Wondfo Biotech Co Ltd?

Kang Ke Ren is the Executives of Guangzhou Wondfo Biotech Co Ltd. Other key executives at Guangzhou Wondfo Biotech Co Ltd include Executives Yu Fang Xia , Directors & executives Li Wen Mei , and Executives Peng Zhong Xiong .

Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) Insider Trades Summary

Over the past 18 months, Kang Ke Ren made no insider transaction in Guangzhou Wondfo Biotech Co Ltd (SZSE:300482). Other recent insider transactions involving Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) include a net sale of 116,000 shares made by He Xiao Wei ,

In summary, during the past 3 months, insiders sold 0 shares of Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,000 shares of Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,000 shares.

Guangzhou Wondfo Biotech Co Ltd (SZSE:300482)'s detailed insider trading history can be found in Insider Trading Tracker table.

Guangzhou Wondfo Biotech Co Ltd Insider Transactions

No Available Data

Kang Ke Ren Mailing Address

Above is the net worth, insider trading, and ownership report for Kang Ke Ren. Currently GuruFocus does not have mailing address information for Kang Ke Ren.

Discussions on Kang Ke Ren

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.